Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$187.51 - $283.98 $17,250 - $26,126
-92 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$238.08 - $288.0 $21,903 - $26,496
92 New
92 $26,000
Q2 2021

Aug 16, 2021

SELL
$235.0 - $310.7 $499,140 - $659,926
-2,124 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$175.6 - $291.43 $372,974 - $618,997
2,124 New
2,124 $575,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.09B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.